2017
DOI: 10.1093/cid/cix646
|View full text |Cite
|
Sign up to set email alerts
|

Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group

Abstract: Background

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

23
128
2
8

Year Published

2018
2018
2021
2021

Publication Types

Select...
4
4
1

Relationship

1
8

Authors

Journals

citations
Cited by 211 publications
(161 citation statements)
references
References 35 publications
23
128
2
8
Order By: Relevance
“…CRE isolates also showed high susceptibility to tigecycline (89.7%) [17]. It should be noted that tigecycline resistance rate of Klebsiella pneumoniae in hematopoietic stem cell transplant patients can reach 16% [18]. Taken together, we inferred that tigecycline exposure increased the risk of CRE BSI might due to intestinal ora disorder.…”
Section: Discussionmentioning
confidence: 63%
“…CRE isolates also showed high susceptibility to tigecycline (89.7%) [17]. It should be noted that tigecycline resistance rate of Klebsiella pneumoniae in hematopoietic stem cell transplant patients can reach 16% [18]. Taken together, we inferred that tigecycline exposure increased the risk of CRE BSI might due to intestinal ora disorder.…”
Section: Discussionmentioning
confidence: 63%
“…The unfolding of multidrug resistance has become a prominent health issue worldwide and may be seen as of great preoccupation, especially in individuals with onco-haematological diseases with febrile neutropenia [8,9,24,26,27]. We witnessed a high proportion of MDR isolates, predominantly ESBL-producing E. coli and K. pneumoniae, and MDR P. aeruginosa.…”
Section: Discussionmentioning
confidence: 99%
“…Crude mortality rates range from 12% to 42%, and attributable mortality rates have been reported as reaching a high of 30%; both of which make immediate empirical antibiotic therapy mandatory in these patients [2e7]. An empirical antibiotic approach is challenging during a time of cumulative antibiotic resistance, and inappropriate antibiotic therapy for multidrug-resistant (MDR) Gram-negative bacilli (GNB) has been related with greater mortality [8,9]. Consequently, broadspectrum antibiotics and even combination therapies are usually endorsed in this population, in spite of most patients not having a documented infection [10,11].…”
Section: Introductionmentioning
confidence: 99%
“…79 IIAT of serious GNB infections is associated with increased mortality and has been the rationale for using broad-spectrum antibiotics upfront in critically ill patients. 32,46,[91][92][93] RDTs along with ASPs have been particularly effective in improving outcomes for these infections. 80 A study from Methodist hospital in Houston integrated RDTs with ASP for the management of gramnegative bacteremia.…”
Section: Evidence In Support Of the Use Of Rdts To Optimize Antibiotimentioning
confidence: 99%